These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10936953)

  • 1. [Comparative study between sodium stibogluconate BP 88 and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity].
    Saldanha AC; Romero GA; Guerra C; Merchan-Hamann E; Macedo Vde O
    Rev Soc Bras Med Trop; 2000; 33(4):383-8. PubMed ID: 10936953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].
    Saldanha AC; Romero GA; Merchan-Hamann E; Magalhães AV; Macedo Vde O
    Rev Soc Bras Med Trop; 1999; 32(4):383-7. PubMed ID: 10495667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative assessment of the efficacy and toxicity of N-methyl-glucamine and BP88 sodium stibogluconate in the treatment of localized cutaneous leishmaniasis].
    Deps PD; Viana MC; Falqueto A; Dietze R
    Rev Soc Bras Med Trop; 2000; 33(6):535-43. PubMed ID: 11175583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.
    Yesilova Y; Surucu HA; Ardic N; Aksoy M; Yesilova A; Oghumu S; Satoskar AR
    J Dermatolog Treat; 2016; 27(1):83-7. PubMed ID: 26105204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications.
    Layegh P; Khademi Z; Afzal Aghaee M; Moghiman T
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):356-8. PubMed ID: 26582874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pentavalent antimonial compounds used in the treatment of cutaneous leishmaniasis on hemogram and biochemical parameters.
    An I; Harman M; Esen M; Çelik H
    Cutan Ocul Toxicol; 2019 Sep; 38(3):294-297. PubMed ID: 31039622
    [No Abstract]   [Full Text] [Related]  

  • 7. Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation.
    Berhe N; Ali A; Hailu A; Yeneneh H
    Acta Trop; 1994 Jun; 57(1):83-90. PubMed ID: 7942358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
    Brito NC; Rabello A; Cota GF
    PLoS One; 2017; 12(9):e0184777. PubMed ID: 28926630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis.
    Kashani MN; Firooz A; Eskandari SE; Ghoorchi MH; Khamesipour A; Khatami A; Javadi A; Dowlati Y
    Eur J Dermatol; 2007; 17(6):513-5. PubMed ID: 17951131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis.
    Berhe N; Abraham Y; Hailu A; Ali A; Mengistu G; Tsige K; Abebe Y
    East Afr Med J; 2001 Nov; 78(11):608-10. PubMed ID: 12219968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
    Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
    Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A; Amini Harandi A
    Ann Trop Med Parasitol; 2003 Jul; 97(5):493-8. PubMed ID: 12930612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
    Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
    Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.
    Gasser RA; Magill AJ; Oster CN; Franke ED; Grögl M; Berman JD
    Clin Infect Dis; 1994 Jan; 18(1):83-90. PubMed ID: 7519887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
    Bermúdez H; Rojas E; Garcia L; Desjeux P; Dujardin JC; Boelaert M; Chappuis F
    Ann Trop Med Parasitol; 2006 Oct; 100(7):591-600. PubMed ID: 16989685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus, AM, Brazil.
    Teixeira AC; Paes MG; Guerra Jde O; Prata A; Silva-Vergara ML
    Rev Inst Med Trop Sao Paulo; 2008; 50(3):157-60. PubMed ID: 18604416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency initiative to reduce leishmaniasis in Afghanistan.
    Querido J
    Lancet Infect Dis; 2004 Oct; 4(10):599. PubMed ID: 15470762
    [No Abstract]   [Full Text] [Related]  

  • 18. Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia.
    Mlika RB; Hamida MB; Hammami H; Jannet SB; Badri T; Fenniche S; Mokhtar I
    Dermatol Ther; 2012; 25(6):615-8. PubMed ID: 23210761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
    Henao HH; Osorio Y; Saravia NG; Gómez A; Travi B
    Biomedica; 2004 Dec; 24(4):393-402. PubMed ID: 15678803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple leg ulcers in a traveler.
    Cardenas GA; Gonzalez-Serva A; Cohen C
    Cleve Clin J Med; 2004 Feb; 71(2):109-12. PubMed ID: 14982193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.